bioengineer.org /3 weeks ago

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 stabilizes the glutamine transporter ASCT2 by blocking SPOP-driven ubiquitin-proteasome degradation, sustaining AKT/mTORC1 signaling in hepatocellular carcinoma cells.

Read source
medicalxpress.com /1 month ago

One gene helps drive growth in two childhood brain tumor groups that lack targeted therapies

Targeting KDM2B or downstream protein complexes it recruits may exploit a vulnerability in high-risk medulloblastoma subgroups that currently lack targeted therapies, according to...

Read source
journals.plos.org /2 weeks ago

A common pathogenic founder variant in Rwandan breast cancer cases

by Achille V. C. Manirakiza, Shakuntala Baichoo, Annette Uwineza, Damas Dukundane, Eulade Rugengamanzi, Janviere Mutamuliza, Allison M. O. Niragira, Raissa Muvunyi, Jeffrey Besada,...

Read source
bioengineer.org /1 week ago

KLHL6 protein drives colorectal cancer liver spread via MBD2 degradation

A study in the Journal of Experimental & Clinical Cancer Research identifies KLHL6 as a driver of colorectal cancer liver metastasis through the degradation of MBD2 and activat...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.